It’s official: #ASH20 will be held as a virtual meeting! While we will miss seeing all of you in person in San Diego, we are excited to reimagine our meeting on an innovative digital platform. Registration reopens 8/31; abstracts now due 8/10 buff.ly/3hmS88I
ASH is strongly urging @ABIMcert to take immediate action to establish a new MOC program that does not involve high-stakes assessments to better serve our members. Read the full text of ASH’s letter: loom.ly/xXS6uqQ@ABMSCert
We'll give our final #ASHKudos to everyone who makes this incredible annual meeting possible, year after year! And thank you to all our wonderful attendees, we'll see you in sunny San Diego for #ASH23 👋😊
New Orleans, here we come… 🛫 🧳 Show us how you’re traveling to #ASH22 & reply with a photo of your journey 📸 Whether you’re commuting from your kitchen to the couch, driving from Denver to downtown NOLA, or flying from Foshan to the French Quarter – we want to see it all!
We're pleased to announce @rosslevinemd of @sloan_kettering with the 2018 William Dameshek Prize for his discoveries in the field of leukemia and myeloproliferative neoplasms buff.ly/2B7TL9m#leusm#MPNsm
In response to a recent @nytimes investigation, we have updated our position statement on #sicklecell trait and will focus on education and training to end this injustice. Read more: loom.ly/ccQapm8
ASH has adopted the term "classical hematology," in place of what was formerly referred to as "benign" or "nonmalignant." Discoveries within #classicalheme have significantly advanced the field & continue to better the lives of those living with non-cancerous blood disorders.
1/2
We hear our members and share your concerns about the new restrictive voter legislation in Georgia. We are reaching out to local leaders in Atlanta to explore appropriate actions ASH can take to apply pressure to repeal the law.
